Avita Medical Inc (RCEL)
10.23 x 7 10.25 x 1
Post-market by (Cboe BZX)
10.25 +0.18 (+1.79%) 04/28/25 [NASDAQ]
10.23 x 7 10.25 x 1
Post-market 10.25 unch (unch) 16:02 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 06-2021 | |
Cash Flows From Operating Activities | |||||
Net Income | -61,845 | -35,381 | -26,665 | N/A | -26,583 |
Depreciation Amortization | 1,126 | 632 | 568 | N/A | 715 |
Accounts receivable | -4,145 | -4,172 | -395 | N/A | -1,399 |
Other Working Capital | -4,678 | -6,574 | -1,196 | N/A | -7,356 |
Other Operating Activity | 20,603 | 7,484 | 8,598 | 0 | 8,722 |
Operating Cash Flow | $-48,939 | $-38,011 | $-19,090 | $N/A | $-25,901 |
Cash Flows From Investing Activities | |||||
PPE Investments | -9,171 | -1,381 | -452 | N/A | -894 |
Purchase Of Investment | -24,504 | -78,757 | -74,362 | N/A | N/A |
Sale Of Investment | 71,200 | 81,811 | 55,555 | N/A | N/A |
Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -280 |
Other Investing Activity | -162 | -66 | -73 | 0 | -280 |
Investing Cash Flow | $37,363 | $1,607 | $-19,332 | $N/A | $-1,174 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 38,762 | N/A | N/A | N/A |
Common Stock Issued | 2,135 | 957 | 900 | N/A | 69,169 |
Common Stock Repurchased | 1,373 | 655 | N/A | N/A | N/A |
Other Financing Activity | 0 | 0 | 0 | 0 | -5,120 |
Financing Cash Flow | $3,508 | $40,374 | $900 | $N/A | $64,049 |
Exchange Rate Effect | N/A | -16 | -26 | N/A | 133 |
Beginning Cash Position | 22,118 | 18,164 | 55,712 | N/A | 73,840 |
End Cash Position | 14,050 | 22,118 | 18,164 | N/A | 110,947 |
Net Cash Flow | $-8,068 | $3,954 | $-37,548 | $N/A | $37,107 |
Free Cash Flow | |||||
Operating Cash Flow | -48,939 | -38,011 | -19,090 | N/A | -25,901 |
Capital Expenditure | -9,171 | -1,381 | -452 | N/A | -894 |
Free Cash Flow | -58,110 | -39,392 | -19,542 | 0 | -26,795 |